Amylyx Pharmaceuticals In... (AMLX)
NASDAQ: AMLX
· Real-Time Price · USD
7.99
-0.01 (-0.12%)
At close: Aug 18, 2025, 3:59 PM
7.86
-1.63%
After-hours: Aug 18, 2025, 07:32 PM EDT
-0.12% (1D)
| Bid | 7.85 |
| Market Cap | 712.45M |
| Revenue (ttm) | -249K |
| Net Income (ttm) | -187.6M |
| EPS (ttm) | -2.49 |
| PE Ratio (ttm) | -3.21 |
| Forward PE | -5.35 |
| Analyst | Buy |
| Ask | 8.4 |
| Volume | 1,172,481 |
| Avg. Volume (20D) | 1,433,780 |
| Open | 7.99 |
| Previous Close | 8.00 |
| Day's Range | 7.86 - 8.18 |
| 52-Week Range | 2.04 - 8.72 |
| Beta | -0.45 |
About AMLX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AMLX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AMLX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+9.51%
Amylyx Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
3 months ago
+4.73%
Amylyx Pharmaceuticals shares are trading higher after Leerink Partners upgraded the stock from Market Perform to Outperform and raised its price target from $4 to $10.
